@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://www.w3.org/ns/prov#> .
@prefix this: <http://purl.org/np/RApMpr1fXbRIeuWoRGMcYTbJ6GOB2wH-Imn6t8Pd51ZV0> .
@prefix sub: <http://purl.org/np/RApMpr1fXbRIeuWoRGMcYTbJ6GOB2wH-Imn6t8Pd51ZV0#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_9700> bl:category bl:Disease .
  
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_9700>;
    rdf:predicate bl:treats;
    rdf:subject <https://identifiers.org/drugbank:DB00218>;
    a rdf:Statement;
    rdfs:label "moxifloxacin ophthalmic solution usp 5 is a topical fluoroquinolone anti infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms corynebacterium species micrococcus luteus staphylococcus aureus staphylococcus epidermidis staphylococcus haemolyticus staphylococcus hominis staphylococcus warneri streptococcus pneumoniae streptococcus viridans group acinetobacter lwoffii haemophilus influenzae haemophilus parainfluenzae chlamydia trachomatis efficacy for this organism was studied in fewer than 1 infections 1 moxifloxacin ophthalmic solution usp 5 is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms corynebacterium species micrococcus luteus staphylococcus aureus staphylococcus epidermidis staphylococcus haemolyticus staphylococcus hominis staphylococcus warneri streptococcus pneumoniae streptococcus viridans group acinetobacter lwoffii haemophilus influenzae haemophilus parainfluenzae chlamydia trachomatis efficacy for this organism was studied in fewer than 1 infections";
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    bl:provided_by <https://w3id.org/um/NeuroDKG>;
    bl:relation schema:TreatmentIndication .
  
  <https://identifiers.org/drugbank:DB00218> bl:category bl:Drug .
}

sub:provenance {
  sub:assertion ns1:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "Ws86x9F1/FxtPC69BLhSEnVPhIvTPC4QBPnmTqS85GjT8gp/yDrlyGulZXl4XBQ+GJDrVE+aWb//fG43U7TevFtUNFWsaCwmSuydDPzP+GYXurSjiRFymzLJ1U+4kXaH63jcvU/Y9gVhlH3f2t+gl9FOQaprHISDz2G6hMO3afw=";
    npx:hasSignatureTarget this: .
  
  this: dcterms:created "2021-06-30T09:07:00.804+02:00"^^xsd:dateTime;
    dcterms:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}